Skip to main content
. Author manuscript; available in PMC: 2008 Nov 6.
Published in final edited form as: Circulation. 2007 Oct 22;116(19):2110–2118. doi: 10.1161/CIRCULATIONAHA.107.729939

TABLE 3.

Association of Physical Activity with Cardiovascular and Coronary Heart Disease Events after Adjusting for Sets of Potential Mediators

Physical Activity, kcal/week
<200 200–599 600–1499 ≥1500 P for Trend
Hazard Ratios (95% Confidence Intervals) Cardiovascular Disease
Age- and treatment-adjusted model 1.00 0.73 (0.61–0.86) 0.68 (0.57–0.80) 0.59 (0.49–0.71) <0.001
Basic model* 1.00 0.86 (0.72–1.04) 0.82 (0.68–0.98) 0.75 (0.61–0.93) 0.01
Basic model plus each set of risk factors below, added one group at a time:
 Blood pressure/hypertension 1.00 0.91 (0.75–1.09) 0.89 (0.74–1.08) 0.82 (0.66–1.01) 0.09
 Body mass index 1.00 0.90 (0.75–1.08) 0.88 (0.73–1.05) 0.78 (0.63–0.96) 0.02
 Hemoglobin A1c/diabetes 1.00 0.89 (0.74–1.07) 0.83 (0.69–1.00) 0.77 (0.62–0.95) 0.02
 Traditional lipids Total, LDL, HDL cholesterol 1.00 0.90 (0.74–1.08) 0.87 (0.72–1.05) 0.80 (0.65–0.99) 0.05
 Novel lipids Lp(a), Apo A1, Apo B100 1.00 0.88 (0.73–1.06) 0.85 (0.71–1.02) 0.79 (0.64–0.97) 0.04
 Homocysteine 1.00 0.87 (0.72–1.04) 0.82 (0.68–0.99) 0.75 (0.61–0.93) 0.01
 Inflammatory/hemostatic hsCRP, fibrinogen, sICAM-1 1.00 0.93 (0.77–1.12) 0.91 (0.75–1.09) 0.83 (0.67–1.03) 0.10
All of the above†† 1.00 0.95 (0.79–1.15) 0.95 (0.79–1.14) 0.90 (0.73–1.11) 0.36
Coronary Heart Disease
Age- and treatment-adjusted model 1.00 0.71 (0.58–0.87) 0.64 (0.52–0.78) 0.48 (0.38–0.62) <0.001
Basic model 1.00 0.84 (0.67––1.06) 0.76 (0.61–0.96) 0.62 (0.48–0.82) 0.001
Basic model plus each set of risk factors below, added one group at a time:
 Blood pressure/hypertension 1.00 0.88 (0.70–1.11) 0.84 (0.67–1.05) 0.68 (0.52–0.89) 0.006
 Body mass index 1.00 0.89 (0.71–1.11) 0.83 (0.66–1.04) 0.65 (0.50–0.85) 0.002
 Hemoglobin A1c/diabetes 1.00 0.87 (0.69–1.08) 0.78 (0.62–0.98) 0.64 (0.49–0.84) 0.001
 Traditional lipids Total, LDL, HDL cholesterol 1.00 0.88 (0.70–1.10) 0.83 (0.66–1.04) 0.67 (0.52–0.88) 0.005
 Novel lipids Lp(a), Apo A1, Apo B100 1.00 0.86 (0.69–1.08) 0.81 (0.64–1.01) 0.67 (0.51–0.87) 0.004
 Homocysteine 1.00 0.85 (0.68–1.06) 0.77 (0.61–0.96) 0.63 (0.48–0.82) 0.001
 Inflammatory/hemostatic hsCRP, fibrinogen, sICAM-1 1.00 0.91 (0.73–1.14) 0.86 (0.68–1.08) 0.70 (0.54–0.92) 0.01
All of the above 1.00 0.93 (0.74–1.17) 0.89 (0.71–1.13) 0.76 (0.58–0.99) 0.05
*

Basic models included age, randomized treatment assignment, smoking, consumption of alcohol, fruits and vegetables, saturated fat, fiber, menopausal status, postmenopausal hormone use, and parental history of myocardial infarction.

Models were adjusted for the variables in the basic model plus each of the sets of risk factors added one group at a time, to separate models.

††

Model included variables in the basic model, plus all sets of risk factors included simultaneously in one model.